Abbas Hussain, previously president of global pharmaceuticals at GlaxoSmithKline Plc, has joined the board of Immunocore Ltd as a non-executive director. Immunocore is developing biologics for cancer based on engineered T cell receptors. Mr Hussain was also GSK’s president for emerging markets. Concurrently Ian Clark, former chief executive of Genentech (Roche), has become a special adviser to the Immunocore board.
Immunocore Ltd announced the appointment on 12 May 2017
Copyright 2017 Evernow Publishing Ltd